| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| FENTANYL LAVIPHARM 25 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63126009 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 50 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63127001 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 50 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63127002 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 50 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63127003 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 50 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63127004 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 50 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63127005 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 50 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63127006 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 50 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63127007 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 50 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63127008 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 50 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63127009 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 75 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63128001 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 75 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63128002 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 75 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63128003 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 75 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63128004 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 75 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63128005 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 75 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63128006 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 75 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63128007 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 75 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63128008 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 75 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63128009 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL TEVA 100 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W70770001 | TEVA B.V. - OLANDA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman